Nomura Securities Starts BioMarin Pharmaceutical Inc. (BMRN) at Neutral, $75 PT
Tweet Send to a Friend
Nomura Securities initiates coverage on BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) with a Neutral. PT $75.00.
"BioMarin's diversified product portfolio—with ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
"BioMarin's diversified product portfolio—with ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
